Improving the binding affinity of a chemical series by systematically probing one of its exit vectors is a medicinal chemistry activity that can benefit from molecular modeling input. Herein, we compare the effectiveness of four approaches in prioritizing building blocks with better potency: selection by a medicinal chemist, manual modeling, docking followed by manual filtering, and free energy calculations (FEP). Our study focused on identifying novel substituents for the apolar S2 pocket of cathepsin L and was conducted entirely in a prospective manner with synthesis and activity determination of 36 novel compounds. We found that FEP selected compounds with improved affinity for 8 out of 10 picks compared to 1 out of 10 for the other appr...
Using computational bioactivity prediction models we identified phosphodiesterase 3B (PDE3B) and cat...
A novel series of noncovalent inhibitors of cathepsin L have been designed to mimic the mode of auto...
Our goal is methods for predicting binding strengths, or binding free energies, between biomolecules...
In this study, we compare the calculated and experimental binding free energies for a combinatorial ...
The role of computation in drug discovery has increased considerably in the past few decades. As of ...
Designing tight-binding ligands is a primary objective of small-molecule drug discovery. Over the pa...
Brinker A, Weber E, Stoll D, et al. Highly potent inhibitors of human cathepsin L identified by scre...
Many limitations of current computer-aided drug design arise from the difficulty of reliably predict...
Computational tools are useful for studying biological systems with an atomistic level of detail. Th...
5 páginas, 1 figura, 2 tablas -- PAGS nros. 5256-5260Fluor-in or out? Based on β,β-difluorinated cyc...
Designing tight-binding ligands is a primary objective of small-molecule drug discovery. Over the pa...
AbstractBackground: The identification of potent small molecule ligands to receptors and enzymes is ...
The main step in a successful drug discovery pipeline is the identification of small potent compound...
Both Monte Carlo statistical mechanics and molecular dynamics are being used to compute relative and...
In silico identification of potent protein inhibitors commonly requires prediction of a ligand bindi...
Using computational bioactivity prediction models we identified phosphodiesterase 3B (PDE3B) and cat...
A novel series of noncovalent inhibitors of cathepsin L have been designed to mimic the mode of auto...
Our goal is methods for predicting binding strengths, or binding free energies, between biomolecules...
In this study, we compare the calculated and experimental binding free energies for a combinatorial ...
The role of computation in drug discovery has increased considerably in the past few decades. As of ...
Designing tight-binding ligands is a primary objective of small-molecule drug discovery. Over the pa...
Brinker A, Weber E, Stoll D, et al. Highly potent inhibitors of human cathepsin L identified by scre...
Many limitations of current computer-aided drug design arise from the difficulty of reliably predict...
Computational tools are useful for studying biological systems with an atomistic level of detail. Th...
5 páginas, 1 figura, 2 tablas -- PAGS nros. 5256-5260Fluor-in or out? Based on β,β-difluorinated cyc...
Designing tight-binding ligands is a primary objective of small-molecule drug discovery. Over the pa...
AbstractBackground: The identification of potent small molecule ligands to receptors and enzymes is ...
The main step in a successful drug discovery pipeline is the identification of small potent compound...
Both Monte Carlo statistical mechanics and molecular dynamics are being used to compute relative and...
In silico identification of potent protein inhibitors commonly requires prediction of a ligand bindi...
Using computational bioactivity prediction models we identified phosphodiesterase 3B (PDE3B) and cat...
A novel series of noncovalent inhibitors of cathepsin L have been designed to mimic the mode of auto...
Our goal is methods for predicting binding strengths, or binding free energies, between biomolecules...